Haematology Flashcards
acute lymphoblastic leukaemia prevalence
most common cancer in paeds
2-5 yrs
males more
trisomy 21 increases
acute lymphoblastic leukaemia pathop
infection, genetic + environment
disruptions in regulation and proliferation of lymphoid precursor cells in bone marrow…excessive production of blast cells, drop in R.B.C, W.B.C and platelets
history ALL
anaemia - lethargy
thrombocytopenia - bruising
leukopenia - infection
bone pain
weight loss
malaise
headache
seizures
examination ALL
pale
excess bruising/bleeding
lymphadenopathy
hepatosplenomegaly
ddx ALL
immune thrombocytopenia, immune deficiency, reactive lymphodenopathy
investigations ALL
FBC - pancytopenia, anaemia, thrombocytopenia
blood film - blast cells
CXR - mediastinal mass
bone marrow aspirate
LP
risk scoring ALL
1-10 yrs - better prognosis
WCC>50 - poorer
females - better
blasts within CSF - poorer
morphology and cytology - effects prognosis
immediate management ALL
resus - high WCC requires hyperhydration to prevent hyperviscosity
if mediastinus mass - steroids
if infection - abx
definitive ALL
chemo - IV, PO, intrathecally
blood products and prophylactic anti-fungal
prognosis ALL
over 90% survive
follow up for 5 years
complications ALL
infertility
avascular necrosis
peripheral neuropathy
anxiety
2 types of acute leukaemia
acute lymphoblastic leukaemia (maj)
acute myeloid leukaemia
acute leukaemia pathophysiology
blood stem cell - can be lymphoid stem cell or myeloid stem cell
lymphoid - WBC
myeloid - RBC, WBC, platelets
genetic mutations in blood progenitor cells…causes developmental arrest…causing immature cells (myeloblasts) - less healthy cells…infection, anaemia, bleeding
childhood AML diagnosis
when bone marrow has 20% or more blasts
classification AML
FAB classification
MO-M7
morphological and histochemical characteristics
leukaemia cells spread
to CNS, skin and gyms
can form solid tumour called chloroma or granylocytic sarcoma
risk factors AML
Down’s syndrome
Li-Fraumeni Syndrome
Aplastic anaemia
Myelodysplasia
Affected sibling
3 main pathological processes acute leukaemia
bone marrow failure due to infiltration by blasts
blast infiltration of other tissues
systemic effects of cytokines released by leukaemic cells and of increased plasma viscosity (leucostasis)
acute leukaemia investigations
FBC- pancytopenia, neutropenic
blood film - blasts, atypical cells, leukoerythroblastic features
CXR - lymph gland enlargement
bone marrow aspirate - definitive diagnosis
LP
biopsy of chloroma
acute leukaemia bone marrow exam
aspirate - response to chemo and risk of relapse
light microscopy - classification
immunophenotyping - identify subtype
initial management acute leukaemia
IV chemo - induction (2 cycles 4 weeks apart) and post remission consolidation
long term managent acute leukaemia
post remission therapy - further chemo
and/or allogeneic haematopoeitic stem cell transplantation
bone marrow transplant - if chemo not work or relapses
complications acute leukaemia
neutropenic sepsis
myelosuppression
N+V
mucositis
hair loss
chemo agent and side effect AML
Doxorubicin Cardiotoxicitiy
Vincristine Peripheral neuropathy
Cyclophosphamide Reduced fertility
Cytarabine Hepatotoxicity
prognosis AML
5 year survival of 66%
if poor cytogenic features or response to therapy - <20% cured
haemophilia genetics
x linked recessive
more common in males
haemophilia A v B
A - factor VIII (more common)
B - factor IX